Cargando…
Peptide Receptor Radionuclide and Octreotide: A Novel Approach for Metastatic Tumor-Induced Osteomalacia
KEY MESSAGES: Octreotide can be used as an adjunctive therapy to increase phosphorus levels in patients with tumor-induced osteomalacia. Malignant phosphaturic mesenchymal tumor (PMT) may benefit from treatment with peptide receptor radionucleotide therapy. CONTEXT: The success of treatment modaliti...
Autores principales: | Nair, Abilash, Chakraborty, Semanti, Dharmshaktu, Pramila, Tandon, Nikhil, Gupta, Yashdeep, Khadgawat, Rajesh, Jabbar, Puthiyaveettil Khadar, Bal, Chandra Sekhar, Agarwal, Shipra, Ganie, Mohd Ashraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686685/ https://www.ncbi.nlm.nih.gov/pubmed/29264524 http://dx.doi.org/10.1210/js.2016-1088 |
Ejemplares similares
-
Slipped Capital Femoral Epiphysis in Primary Hyperparathyroidism - Case Report with Literature Review
por: George, Geena Susan, et al.
Publicado: (2019) -
Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis
por: Soumya, Sarayu, et al.
Publicado: (2021) -
Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism
por: Jayakumari, Chellama, et al.
Publicado: (2019) -
Antiepileptic therapy, osteomalacia, and synchronous fractures: Don’t lose looser zones
por: Dharmshaktu, Ganesh Singh
Publicado: (2017) -
Normative range of various serum hormonal parameters among Indian women of reproductive age: ICMR-PCOS task force study outcome
por: Ganie, Mohd Ashraf, et al.
Publicado: (2023)